PRED-G
LOE ApproachingNDAOPHTHALMICOINTMENT
Approved
Dec 1989
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Data completeness
1/8 — Limited
Drug data last refreshed 2d ago · AI intelligence enriched 3w ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
PRED-G is an ophthalmic ointment containing a small-molecule active ingredient, approved in 1989 for eye-related indications. The product's exact mechanism and indications are not publicly detailed in available sources, but the ointment formulation suggests topical ocular anti-inflammatory or antimicrobial use. As a mature product with approaching loss of exclusivity, PRED-G represents a legacy franchise in AbbVie's ophthalmology portfolio.
LOE Approaching
As an approaching LOE product with moderate competitive pressure (30), PRED-G teams are likely focused on defending market share and managing generic transition rather than expansion, suggesting smaller or restructuring commercial organizations.
Mechanism of Action
Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Career Relevance
Working on PRED-G offers limited career growth opportunities given zero linked job openings and the product's LOE status. This role is best suited for professionals seeking defensive strategy experience or those managing portfolio transitions rather than building growth credentials.
Brand ManagerField Sales Representative
Worked on PRED-G at AbbVie? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.